CoChat

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases

Open access
Ai, Xiaopeng, Yu, Peiling, Peng, Lixia, Luo, Liuling, Liu, Jia, Li, Shengqian, Lai, Xianrong, Luan, Fei, Meng, Xianli · 2021 · Frontiers in Pharmacology
Cited by 218

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Traditional Chinese medicine plays a significant role in the treatment of various diseases and has attracted increasing attention for clinical applications. Vascular diseases affecting vasculature in the heart, cerebrovascular disease, atherosclerosis, and diabetic complications have compromised quality of life for affected individuals and increase the burden on health care services. Berberine, a naturally occurring isoquinoline alkaloid form Rhizoma coptidis, is widely used in China as a folk medicine for its antibacterial and anti-inflammatory properties. Promisingly, an increasing number of studies have identified several cellular and molecular targets for berberine, indicating its potential as an alternative therapeutic strategy for vascular diseases, as well as providing novel evidence that supports the therapeutic potential of berberine to combat vascular diseases. The purpose of this review is to comprehensively and systematically describe the evidence for berberine as a therapeutic agent in vascular diseases, including its pharmacological effects, molecular mechanisms, and pharmacokinetics. According to data published so far, berberine shows remarkable anti-inflammatory, antioxidant, antiapoptotic, and antiautophagic activity via the regulation of multiple signaling pathways, including AMP-activated protein kinase (AMPK), nuclear factor κB (NF-κB), mitogen-activated protein kinase silent information regulator 1 (SIRT-1), hypoxia-inducible factor 1α (HIF-1α), vascular endothelial growth factor phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), janus kinase 2 (JAK-2), Ca 2+ channels, and endoplasmic reticulum stress. Moreover, we discuss the existing limitations of berberine in the treatment of vascular diseases, and give corresponding measures. In addition, we propose some research perspectives and challenges, and provide a solid evidence base from which further studies can excavate novel effective drugs from Chinese medicine monomers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2021.762654

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 239

  1. Aggarwal, 2020, Post-translational Modification Crosstalk and Hotspots in Sirtuin Interactors Implicated in Cardiovascular Diseases, Front. Genet., 11, 356, 10.3389/fgene.2020.00356 · DOI
  2. Agrawal, 2018, Dyslipidaemia in Nephrotic Syndrome: Mechanisms and Treatment, Nat. Rev. Nephrol., 14, 57, 10.1038/nrneph.2017.155 · DOI · Paper page
  3. Ai, 2019, Amelioration of Dry Eye Syndrome in Db/db Mice with Diabetes Mellitus by Treatment with Tibetan Medicine Formula Jikan Mingmu Drops, J. Ethnopharmacol., 241, 111992, 10.1016/j.jep.2019.111992 · DOI
  4. Ai, 2020, A Review of Traditional Chinese Medicine on Treatment of Diabetic Retinopathy and Involved Mechanisms, Biomed. Pharmacother., 132, 110852, 10.1016/j.biopha.2020.110852 · DOI
  5. Ajjan, 2021, Antithrombotic Therapy in Diabetes: Which, when, and for How Long?, Eur. Heart J., 42, 2235, 10.1093/eurheartj/ehab128 · DOI
  6. Akhmedov, 2021, Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1): A Crucial Driver of Atherosclerotic Cardiovascular Disease, Eur. Heart J., 42, 1797, 10.1093/eurheartj/ehaa770 · DOI
  7. Al Rifai, 2021, Prevalence and Determinants of Difficulty in Accessing Medical Care in U.S. Adults, Am. J. Prev. Med., 61, 492, 10.1016/j.amepre.2021.03.026 · DOI
  8. Allijn, 2017, Liposome Encapsulated Berberine Treatment Attenuates Cardiac Dysfunction after Myocardial Infarction, J. Control Release., 247, 127, 10.1016/j.jconrel.2016.12.042 · DOI
  9. Altoé, 2021, Doxycycline Hyclate Modulates Antioxidant Defenses, Matrix Metalloproteinases, and COX-2 Activity Accelerating Skin Wound Healing by Secondary Intention in Rats, Oxid. Med. Cel. Longev., 2021, 4681041, 10.1155/2021/4681041 · DOI
  10. Antila, 2017, Development and Plasticity of Meningeal Lymphatic Vessels, J. Exp. Med., 214, 3645, 10.1084/jem.20170391 · DOI · Paper page
  11. Atanasov, 2021, Natural Products in Drug Discovery: Advances and Opportunities, Nat. Rev. Drug Discov., 20, 200, 10.1038/s41573-020-00114-z · DOI · Paper page
  12. Azegami, 2021, Vaccination against Receptor for Advanced Glycation End Products Attenuates the Progression of Diabetic Kidney Disease, Diabetes, 70, 2147, 10.2337/db20-1257 · DOI
  13. Banaei, 2020, Preconditioning Effect of High-Intensity Interval Training (HIIT) and Berberine Supplementation on the Gene Expression of Angiogenesis Regulators and Caspase-3 Protein in the Rats with Myocardial Ischemia-Reperfusion (IR) Injury, Biomed. Res. Int., 2020, 4104965, 10.1155/2020/4104965 · DOI
  14. Bertorello, 2015, Increased Arterial Blood Pressure and Vascular Remodeling in Mice Lacking Salt-Inducible Kinase 1 (SIK1), Circ. Res., 116, 642, 10.1161/CIRCRESAHA.116.304529 · DOI
  15. Bisserier, 2021, Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension, Circulation, 144, 52, 10.1161/CIRCULATIONAHA.120.047978 · DOI
  16. Brown, 2021, Arterial Platelet Adhesion in Atherosclerosis-Prone Arteries of Obese, Insulin-Resistant Nonhuman Primates, J. Am. Heart Assoc., 10, e019413, 10.1161/JAHA.120.019413 · DOI
  17. Brown, 2017, Current Understanding of Atherogenesis, Am. J. Med., 130, 268, 10.1016/j.amjmed.2016.10.022 · DOI
  18. Chang, 2012, Berberine Attenuates Ischemia-Reperfusion Injury via Regulation of Adenosine-5'-Monophosphate Kinase Activity in Both Non-ischemic and Ischemic Areas of the Rat Heart, Cardiovasc. Drugs Ther., 26, 467, 10.1007/s10557-012-6422-0 · DOI
  19. Chang, 2016, Lipid Profiling of the Therapeutic Effects of Berberine in Patients with Nonalcoholic Fatty Liver Disease, J. Transl. Med., 14, 266, 10.1186/s12967-016-0982-x · DOI · Paper page
  20. Chang, 2021, Quercetin Improves Cardiomyocyte Vulnerability to Hypoxia by Regulating SIRT1/TMBIM6-Related Mitophagy and Endoplasmic Reticulum Stress, Oxid. Med. Cell Longev., 2021, 5529913, 10.1155/2021/5529913 · DOI
  21. Chen, 2018, Berberine Attenuates Apoptosis in Rat Retinal Müller Cells Stimulated with High Glucose via Enhancing Autophagy and the AMPK/mTOR Signaling, Biomed. Pharmacother., 108, 1201, 10.1016/j.biopha.2018.09.140 · DOI
  22. Chen, 2021, A Comparative Investigation of the Interaction and Pharmacokinetics of Hemoglobin with Berberine and its Oxymetabolite, J. Pharm. Biomed. Anal., 199, 114032, 10.1016/j.jpba.2021.114032 · DOI
  23. Chen, 2020, circDLPAG4/HECTD1 Mediates Ischaemia/reperfusion Injury in Endothelial Cells via ER Stress, RNA Biol., 17, 240, 10.1080/15476286.2019.1676114 · DOI
  24. Chen, 2019, Berberine Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension via Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling, J. Cell Physiol., 234, 17482, 10.1002/jcp.28370 · DOI
  25. Cheng, 2017, Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke, Oxid Med. Cell Longev, 2017, 8526438, 10.1155/2017/8526438 · DOI · Paper page
  26. Cheng, 2010, 8,8-Dimethyldihydroberberine with Improved Bioavailability and Oral Efficacy on Obese and Diabetic Mouse Models, Bioorg. Med. Chem., 18, 5915, 10.1016/j.bmc.2010.06.085 · DOI
  27. Chong, 2021, Tissue Factor Cytoplasmic Domain Exacerbates Post-Infarct Left Ventricular Remodeling via Orchestrating Cardiac Inflammation and Angiogenesis, Theranostics, 11, 9243, 10.7150/thno.63354 · doi:10.7150/thno.63354
  28. Choudhary, 2011, Bosentan Attenuates Right Ventricular Hypertrophy and Fibrosis in Normobaric Hypoxia Model of Pulmonary Hypertension, J. Heart Lung Transpl., 30, 827, 10.1016/j.healun.2011.03.010 · DOI
  29. Cook, 2012, Myeloperoxidase-derived Oxidants Inhibit Sarco/Endoplasmic Reticulum Ca2+-Atpase Activity and Perturb Ca2+ Homeostasis in Human Coronary Artery Endothelial Cells, Free Radic. Biol. Med., 52, 951, 10.1016/j.freeradbiomed.2011.12.001 · DOI · Paper page
  30. Cryer, 2016, Diabetes and Hypertension: A Comparative Review of Current Guidelines, J. Clin. Hypertens. (Greenwich), 18, 95, 10.1111/jch.12638 · DOI
  31. Cui, 2015, Poor Permeability and Absorption Affect the Activity of Four Alkaloids from Coptis, Mol. Med. Rep., 12, 7160, 10.3892/mmr.2015.4288 · DOI · Paper page
  32. Cui, 2018, Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability, Molecules, 24, 103, 10.3390/molecules24010103 · DOI · Paper page
  33. Dai, 2009, Mild Cognitive Impairment and Alzheimer Disease: Patterns of Altered Cerebral Blood Flow at MR Imaging, Radiology, 250, 856, 10.1148/radiol.2503080751 · DOI · Paper page
  34. de Ferranti, 2018, Association of Initially Normal Coronary Arteries with Normal Findings on Follow-Up Echocardiography in Patients with Kawasaki Disease, JAMA Pediatr., 172, e183310, 10.1001/jamapediatrics.2018.3310 · doi:10.1001/jamapediatrics.2018.3310
  35. Detillieux, 2003, Biological Activities of Fibroblast Growth Factor-2 in the Adult Myocardium, Cardiovasc. Res., 57, 8, 10.1016/s0008-6363(02)00708-3 · DOI · Paper page
  36. Dewanjee, 2020, Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy, Int. J. Mol. Sci., 21, 2217, 10.3390/ijms21062217 · DOI · Paper page
  37. Doña, 2020, Progress in Understanding Hypersensitivity Reactions to Nonsteroidal Anti‐inflammatory Drugs, Allergy, 75, 561, 10.1111/all.14032 · DOI
  38. Fang, 2018, Berberine Ameliorates Neonatal Necrotizing Enterocolitis by Activating the Phosphoinositide 3-kinase/protein Kinase B Signaling Pathway, Exp. Ther. Med., 15, 3530, 10.3892/etm.2018.5858 · DOI
  39. Fang, 2021, Secretogranin II Impairs Tumor Growth and Angiogenesis by Promoting Degradation of Hypoxia‐inducible Factor‐1α in Colorectal Cancer, Mol. Oncol., 23, 1, 10.1002/1878-0261.13044 · DOI
  40. Feng, 2017, Comparative Effect of Berberine and its Derivative 8-Cetylberberine on Attenuating Atherosclerosis in ApoE-/- Mice, Int. Immunopharmacol., 43, 195, 10.1016/j.intimp.2016.12.001 · DOI
  41. Feng, 2019, Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics, Theranostics, 9, 1923, 10.7150/thno.30787 · DOI · Paper page
  42. Feng, 2021, Pharmacokinetics and Excretion of Berberine and its Nine Metabolites in Rats, Front. Pharmacol., 11, 594852, 10.3389/fphar.2020.594852 · DOI · Paper page
  43. Feng, 2020, ATP-citrate Lyase (ACLY) in Lipid Metabolism and Atherosclerosis: An Updated Review, Prog. Lipid. Res., 77, 101006, 10.1016/j.plipres.2019.101006 · DOI · Paper page
  44. Ferron, 2011, T-type Ca²+ Signalling Regulates Aldosterone-Induced CREB Activation and Cell Death through PP2A Activation in Neonatal Cardiomyocytes, Cardiovasc. Res., 90, 105, 10.1093/cvr/cvq379 · DOI
  45. Fatima, 2021, Sestrin2 Suppression Aggravates Oxidative Stress and Apoptosis in Endothelial Cells Subjected to Pharmacologically Induced Endoplasmic Reticulum Stress, Eur. J. Pharmacol., 907, 17424, 10.1016/j.ejphar.2021.174247 · DOI
  46. Frangogiannis, 2005, Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts, Circulation, 111, 2935, 10.1161/CIRCULATIONAHA.104.510354 · DOI · Paper page
  47. Gaba, 2021, An Insight into the Medicinal Attributes of Berberine Derivatives: A Review, Bioorg. Med. Chem., 38, 116143, 10.1016/j.bmc.2021.116143 · DOI
  48. Galvani, 2015, HDL-bound Sphingosine 1-Phosphate Acts as a Biased Agonist for the Endothelial Cell Receptor S1P1 to Limit Vascular Inflammation, Sci. Signal., 8, ra79, 10.1126/scisignal.aaa2581 · DOI · Paper page
  49. Gan, 2020, Circular RNA_101237 Mediates Anoxia/reoxygenation Injury by Targeting let-7a-5p/IGF2BP3 in C-ardiomyocytes, Int. J. Mol. Med., 45, 451, 10.3892/ijmm.2019.4441 · DOI
  50. Gao, 2018, Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies, Curr. Alzheimer. Res., 15, 283, 10.2174/1567205014666170417111859 · DOI · Paper page
  51. Garikipati, 2019, Circular RNA CircFndc3b Modulates Cardiac Repair after Myocardial Infarction via FUS/VEGF-A Axis, Nat. Commun., 10, 4317, 10.1038/s41467-019-11777-7 · DOI · Paper page
  52. Garry, 2021, Direct Reprogramming as a Route to Cardiac Repair, Semin. Cell Dev. Biol., 00128, 10.1016/j.semcdb.2021.05.019 · DOI
  53. Gawel, 2020, The Influence of Palmatine Isolated from Berberis Sibirica Radix on Pentylenetetrazole-Induced Seizures in Zebrafish, Cells, 9, 1233, 10.3390/cells9051233 · DOI
  54. Geng, 2016, Berberine Improves Mesenteric Artery Insulin Sensitivity through Up-Regulating Insulin Receptor-Mediated Signalling in Diabetic Rats, Br. J. Pharmacol., 173, 1569, 10.1111/bph.13466 · DOI · Paper page
  55. Golia, 2014, Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target, Curr. Atheroscler. Rep., 16, 435, 10.1007/s11883-014-0435-z · DOI · Paper page
  56. Gong, 2021, Protective or Harmful: The Dual Roles of Autophagy in Diabetic Retinopathy, Front. Med. (Lausanne), 8, 644121, 10.3389/fmed.2021.644121 · DOI
  57. Gong, 2020, Resveratrol Inhibits Lipopolysaccharide-Induced Extracellular Matrix Accumulation and Inflammation in Rat Glomerular Mesangial Cells by SphK1/S1P2/NF-Κb Pathway, Diabetes Metab. Syndr. Obes., 13, 4495, 10.2147/DMSO.S278267 · DOI
  58. Guan, 2018, Orally Administered Berberine Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice through Promoting Activation of PPAR-γ and Subsequent Expression of HGF in Colons, Toxicol. Appl. Pharmacol., 343, 1, 10.1016/j.taap.2018.02.001 · DOI
  59. Guida, 2014, Alternative Dosing Schedules for Sunitinib as a Treatment of Patients with Metastatic Renal Cell Carcinoma, Crit. Rev. Oncol. Hematol., 92, 208, 10.1016/j.critrevonc.2014.07.006 · DOI
  60. Guo, Precise Deciphering of Brain Vasculatures and Microscopic Tumors with Dual NIR-II Fluorescence and Photoacoustic Imaging, Adv. Mater., 31, e1902504, 10.1002/adma.201902504 · DOI · Paper page
  61. Guo, Liver-Target Nanotechnology Facilitates Berberine to Ameliorate Cardio-Metabolic Diseases, Nat. Commun., 10, 1981, 10.1038/s41467-019-09852-0 · DOI
  62. Guo, 2016, Berberine Protects Human Umbilical Vein Endothelial Cells against LPS-Induced Apoptosis by Blocking JNK-Mediated Signaling, Evid. Based Complement. Alternat. Med., 2016, 6983956, 10.1155/2016/6983956 · DOI
  63. Guzik, 2017, Oxidative Stress, Inflammation, and Vascular Aging in Hypertension, Hypertension, 70, 660, 10.1161/HYPERTENSIONAHA.117.07802 · DOI · Paper page
  64. Habtemariam, The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches, Biomedicines, 8, 90, 10.3390/biomedicines8040090 · DOI
  65. Han, 2019, Novel Carbohydrate Modified Berberine Derivatives: Synthesis and In Vitro Anti-diabetic Investigation, Medchemcomm, 10, 598, 10.1039/c9md00036d · DOI
  66. Han, Mori Ramulus Inhibits Pancreatic β-Cell Apoptosis and Prevents Insulin Resistance by Restoring Hepatic Mitochondrial Function, Antioxidants (Basel), 10, 901, 10.3390/antiox10060901 · DOI
  67. Hao, 2011, Amelioration Effects of Berberine on Diabetic Microendothelial Injury Model by the Combination of High Glucose and Advanced Glycation End Products In Vitro, Eur. J. Pharmacol., 654, 320, 10.1016/j.ejphar.2010.12.030 · DOI
  68. He, 2018, Berberine Exerts a Protective Effect on Gut-Vascular Barrier via the Modulation of the Wnt/Beta-Catenin Signaling Pathway during Sepsis, Cell. Physiol. Biochem., 49, 1342, 10.1159/000493412 · doi:10.1159/000493412
  69. Henning, 2018, Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders, Cardiovasc. Toxicol., 18, 493, 10.1007/s12012-018-9462-2 · DOI
  70. Hu, 2019, Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers, Biomed. Res. Int., 2019, 6831520, 10.1155/2019/6831520 · DOI
  71. Hua, 2007, Determination of Berberine in Human Plasma by Liquid Chromatography-Electrospray Ionization-Mass Spectrometry, J. Pharm. Biomed. Anal., 44, 931, 10.1016/j.jpba.2007.03.022 · DOI · Paper page
  72. Huang, 2021, Extracellular Vesicles in Cardiovascular Disease, Adv. Clin. Chem., 103, 47, 10.1016/bs.acc.2020.08.006 · DOI
  73. Huang, 2018, Capsaicin Prevents Mitochondrial Damage, Protects Cardiomyocytes Subjected to Anoxia/reoxygenation Injury Mediated by 14-3-3η/Bcl-2, Eur. J. Pharmacol., 819, 43, 10.1016/j.ejphar.2017.11.028 · DOI
  74. Hui, 2010, Adipocyte Fatty Acid-Binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving C-Jun NH2-Terminal Kinases and Activator Protein-1, J. Biol. Chem., 285, 10273, 10.1074/jbc.M109.097907 · DOI · Paper page
  75. Imenshahidi, 2019, Berberine and Barberry (Berberis Vulgaris): A Clinical Review, Phytother. Res., 33, 504, 10.1002/ptr.6252 · DOI · Paper page
  76. Insull, 2009, The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment, Am. J. Med., 122, S3, 10.1016/j.amjmed.2008.10.013 · DOI · Paper page
  77. James, 2014, 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8), JAMA, 311, 507, 10.1001/jama.2013.284427 · DOI · Paper page
  78. Jang, 2017, Quinic Acid Inhibits Vascular Inflammation in TNF-α-Stimulated Vascular Smooth Muscle Cells, Biomed. Pharmacotherpharmacother, 96, 563, 10.1016/j.biopha.2017.10.021 · DOI
  79. Ji, 2021, Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases, Int. J. Mol. Sci., 22, 5770, 10.3390/ijms22115770 · DOI
  80. Ji, 2021, Neurovascular Regulation in Diabetic Retinopathy and Emerging Therapies, Cell. Mol. Life Sci., 78, 5977, 10.1007/s00018-021-03893-9 · DOI
  81. Jia, 2012, Berberine Suppresses Amyloid-Beta-Induced Inflammatory Response in Microglia by Inhibiting Nuclear Factor-kappaB and Mitogen-Activated Protein Kinase Signalling Pathways, J. Pharm. Pharmacol., 64, 1510, 10.1111/j.2042-7158.2012.01529.x · DOI · Paper page
  82. Jiang, 2011, Berberine Attenuates Lipopolysaccharide-Induced Extracelluar Matrix Accumulation and Inflammation in Rat Mesangial Cells: Involvement of NF-Κb Signaling Pathway, Mol. Cel. Endocrinol., 331, 34, 10.1016/j.mce.2010.07.023 · DOI
  83. Jie, 2011, Berberine Inhibits Angiogenic Potential of Hep G2 Cell Line through VEGF Down-Regulation In Vitro, J. Gastroenterol. Hepatol., 26, 179, 10.1111/j.1440-1746.2010.06389.x · DOI
  84. Jin, 2018, Berberine Inhibits Angiogenesis in Glioblastoma Xenografts by Targeting the VEGFR2/ERK Pathway, Pharm. Biol., 56, 665, 10.1080/13880209.2018.1548627 · DOI
  85. Jin, 2019, BDNF-mediated Mitophagy Alleviates High-Glucose-Induced Brain Microvascular Endothelial Cell Injury, Apoptosis, 24, 511, 10.1007/s10495-019-01535-x · DOI
  86. Jonsson, 2017, Role of Gut Microbiota in Atherosclerosis, Nat. Rev. Cardiol., 14, 79, 10.1038/nrcardio.2016.183 · DOI · Paper page
  87. Jove, 2019, Precision Pharmacology: Mass Spectrometry Imaging and Pharmacokinetic Drug Resistance, Crit. Rev. Oncol. Hematol., 141, 153, 10.1016/j.critrevonc.2019.06.008 · DOI
  88. Kattoor, 2019, LOX-1: Regulation, Signaling and its Role in Atherosclerosis, Antioxidants (Basel), 8, 218, 10.3390/antiox8070218 · DOI · Paper page
  89. Khoramzadeh, 2019, Roles of Endothelin B Receptors and Endothelial Nitric Oxide Synthase in the Regulation of Pulmonary Hemodynamic in Cirrhotic Rats, J. Cardiovasc. Pharmacol., 73, 178, 10.1097/FJC.0000000000000650 · doi:10.1097/fjc.0000000000000650
  90. Kim, 2009, Silibinin Prevents TPA-Induced MMP-9 Expression and VEGF Secretion by Inactivation of the Raf/MEK/ERK Pathway in MCF-7 Human Breast Cancer Cells, Phytomedicine, 16, 573, 10.1016/j.phymed.2008.11.006 · DOI
  91. Kim, 2013, Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells, Cell Physiol. Biochem., 32, 1541, 10.1159/000356591 · DOI
  92. Konukoglu, 2017, Endothelial Dysfunction and Hypertension, Adv. Exp. Med. Biol., 956, 511, 10.1007/5584_2016_90 · DOI · Paper page
  93. Kostov, 2018, Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension, Int. J. Mol. Sci., 19, 1724, 10.3390/ijms19061724 · DOI · Paper page
  94. Krüger-Genge, 2019, Vascular Endothelial Cell Biology: An Update, Int. J. Mol. Sci., 20, 4411, 10.3390/ijms20184411 · DOI · Paper page
  95. Kumar, 2015, Current Knowledge and Pharmacological Profile of Berberine: An Update, Eur. J. Pharmacol., 761, 288, 10.1016/j.ejphar.2015.05.068 · DOI · Paper page
  96. Lai, 2018, Amelioration of Diabetic Nephropathy in Db/db Mice Treated with Tibetan Medicine Formula Siwei Jianghuang Decoction Powder Extract, Sci. Rep., 8, 16707, 10.1038/s41598-018-35148-2 · DOI
  97. Lee, 2018, Network Pharmacology-Based Prediction of Active Compounds and Molecular Targets in Yijin-Tang Acting on Hyperlipidaemia and Atherosclerosis, J. Ethnopharmacol., 221, 151, 10.1016/j.jep.2018.04.027 · DOI
  98. Lefferts, 2016, Effect of Hypoxia on Cerebrovascular and Cognitive Function during Moderate Intensity Exercise, Physiol. Behav., 165, 108, 10.1016/j.physbeh.2016.07.003 · DOI
  99. Leyva-Peralta, 2019, Berberine as Source of Antiproliferative Hybrid Compounds: In Vitro Antiproliferative Activity and Quantitative Structure-Activity Relationship, Anticancer Agents Med. Chem., 19, 1820, 10.2174/1871520619666190503121820 · DOI
  100. Li, Berberine Activates Peroxisome Proliferator-Activated Receptor Gamma to Increase Atherosclerotic Plaque Stability in Apoe-/- Mice with Hyperhomocysteinemia, J. Diabetes Investig., 7, 824, 10.1111/jdi.12516 · DOI
  101. Li, Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 In Vivo, Circulation, 134, 1752, 10.1161/CIRCULATIONAHA.116.017949 · DOI
  102. Li, 2019, Natural Berberine-Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application, ACS Nano, 13, 6770, 10.1021/acsnano.9b01346 · DOI · Paper page
  103. Li, Berberine Attenuates Vascular Remodeling and Inflammation in a Rat Model of Metabolic Syndrome, Biol. Pharm. Bull., 38, 862, 10.1248/bpb.b14-00828 · DOI
  104. Li, Effect of Berberine on Promoting the Excretion of Cholesterol in High-Fat Diet-Induced Hyperlipidemic Hamsters, J. Transl. Med., 13, 278, 10.1186/s12967-015-0629-3 · DOI · Paper page
  105. Li, Succinate Induces Synovial Angiogenesis in Rheumatoid Arthritis through Metabolic Remodeling and HIF-1α/VEGF axis, Free Radic. Biol. Med., 126, 1, 10.1016/j.freeradbiomed.2018.07.009 · DOI
  106. Li, Pharmacological Effects and Mechanisms of Chinese Medicines Modulating NLRP3 Inflammasomes in Ischemic Cardio/Cerebral Vascular Disease, Am. J. Chin. Med., 46, 1727, 10.1142/S0192415X18500878 · DOI
  107. Li, Berberine Reduces Gut-Vascular Barrier Permeability via Modulation of ApoM/S1P Pathway in a Model of Polymicrobial Sepsis, Life Sci., 261, 118460, 10.1016/j.lfs.2020.118460 · DOI
  108. Lian, 2016, Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease, J. Neurosci., 36, 577, 10.1523/JNEUROSCI.2117-15.2016 · DOI · Paper page
  109. Liang, 2020, The Critical Role of Endothelial Function in Fine Particulate Matter-Induced Atherosclerosis, Part. Fibre. Toxicol., 17, 61, 10.1186/s12989-020-00391-x · DOI
  110. Lin, 2020, Synthesis and In Vitro Photocytotoxicity of 9-/13-Lipophilic Substituted Berberine Derivatives as Potential Anticancer Agents, Molecules, 25, 677, 10.3390/molecules25030677 · DOI
  111. Linton, 2016, Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis, Circ. J., 80, 2259, 10.1253/circj.CJ-16-0924 · DOI · Paper page
  112. Liss, 2021, General Health Checks in Adult Primary Care: A Review, JAMA, 325, 2294, 10.1001/jama.2021.6524 · DOI
  113. Liu, 2018, Effect of Berberine on Angiogenesis and HIF-1α/VEGF Signal Transduction Pathway in Rats with Cerebral Ischemia - Reperfusion Injury, J. Coll. Physicians Surg. Pak., 28, 753
  114. Liu, Berberine Improves Endothelial Function by Inhibiting Endoplasmic Reticulum Stress in the Carotid Arteries of Spontaneously Hypertensive Rats, Biochem. Biophys. Res. Commun., 458, 796, 10.1016/j.bbrc.2015.02.028 · DOI
  115. Liu, 2019, Inhibition of Src Activation Reverses Pulmonary Vascular Remodeling in Experimental Pulmonary Arterial Hypertension via Akt/mTOR/HIF-1 Signaling Pathway, Exp. Cell Res., 380, 36, 10.1016/j.yexcr.2019.02.022 · DOI
  116. Liu, Berberine Inhibits Tumor Necrosis Factor-α-Induced Expression of Inflammatory Molecules and Activation of Nuclear Factor-Κb via the Activation of AMPK in Vascular Endothelial Cells, Mol. Med. Rep., 12, 5580, 10.3892/mmr.2015.4061 · DOI
  117. Liu, 2014, Berberine Suppresses In Vitro Migration of Human Aortic Smooth Muscle Cells through the Inhibitions of MMP-2/9, u-PA, AP-1, and NF-Κb, BMB Rep., 47, 388, 10.5483/bmbrep.2014.47.7.186 · DOI
  118. Liu, Effects of Berberine on Matrix Accumulation and NF-Kappa B Signal Pathway in Alloxan-Induced Diabetic Mice with Renal Injury, Eur. J. Pharmacol., 638, 150, 10.1016/j.ejphar.2010.04.033 · DOI
  119. Liu, 2020, Berberine Prevents Primary Peritoneal Adhesion and Adhesion Reformation by Directly Inhibiting TIMP-1, Acta Pharm. Sin. B., 10, 812, 10.1016/j.apsb.2020.02.003 · DOI
  120. Lockshin, 2018, Interleukin 17, Inflammation, and Cardiovascular Risk in Patients with Psoriasis, J. Am. Acad. Dermatol., 79, 345, 10.1016/j.jaad.2018.02.040 · DOI
  121. Lopes, 2020, Berberine Associated Photodynamic Therapy Promotes Autophagy and Apoptosis via ROS Generation in Renal Carcinoma Cells, Biomed. Pharmacother., 123, 109794, 10.1016/j.biopha.2019.109794 · DOI
  122. Lorenzen, 2016, Long Noncoding RNAs in Kidney and Cardiovascular Diseases, Nat. Rev. Nephrol., 12, 360, 10.1038/nrneph.2016.51 · DOI · Paper page
  123. Lu, 2015, Attenuation of Cardiac Dysfunction and Remodeling of Myocardial Infarction by microRNA-130a Are Mediated by Suppression of PTEN and Activation of PI3K Dependent Signaling, J. Mol. Cel. Cardiol., 89, 87, 10.1016/j.yjmcc.2015.10.011 · DOI
  124. Lu, 2018, Beneficial Effects Exerted by Paeonol in the Management of Atherosclerosis, Oxid. Med. Cel. Longev., 2018, 1098617, 10.1155/2018/1098617 · DOI
  125. Lundberg, 2021, Oxidative Stress Response in Regulatory and Conventional T Cells: A Comparison between Patients with Chronic Coronary Syndrome and Healthy Subjects, J. Transl. Med., 19, 241, 10.1186/s12967-021-02906-2 · DOI
  126. Luo, 2021, Structure-Guided Modification of Isoxazole-type FXR Agonists: Identification of a Potent and Orally Bioavailable FXR Modulator, Eur. J. Med. Chem., 209, 112910, 10.1016/j.ejmech.2020.112910 · DOI
  127. Luo, 2018, Berberine Attenuates Pulmonary Arterial Hypertension via Protein Phosphatase 2A Signaling Pathway Both In Vivo and In Vitro, J. Cel. Physiol., 233, 9750, 10.1002/jcp.26940 · DOI
  128. Lyu, 2021, Treatment of Rheumatoid Arthritis by Serum Albumin Nanoparticles Coated with Mannose to Target Neutrophils, ACS Appl. Mater. Inter., 13, 266, 10.1021/acsami.0c19468 · DOI
  129. Ma, 2013, Excretion of Berberine and its Metabolites in Oral Administration in Rats, J. Pharm. Sci., 102, 4181, 10.1002/jps.23718 · DOI
  130. Ma, 2020, Functional Nano-Vector Boost Anti-atherosclerosis Efficacy of Berberine in Apoe (-/-) Mice, Acta Pharm. Sin. B., 10, 1769, 10.1016/j.apsb.2020.03.005 · DOI · Paper page
  131. Ma, 2017, Berberine Reduced Blood Pressure and Improved Vasodilation in Diabetic Rats, J. Mol. Endocrinol., 59, 191, 10.1530/JME-17-0014 · DOI · Paper page
  132. Ma, 2016, Berberine Alleviates the Cerebrovascular Contractility in Streptozotocin-Induced Diabetic Rats through Modulation of Intracellular Ca²⁺ Handling in Smooth Muscle Cells, Cardiovasc. Diabetol., 15, 63, 10.1186/s12933-016-0382-9 · doi:10.1186/s12933-016-0382-9
  133. Maier, 2020, Impact of Intermittent Functional Internal Iliac Artery Occlusion on Spinal Cord Blood Supply during TEVAR, Thorac. Cardiovasc. Surg., 68, 315, 10.1055/s-0039-1688474 · doi:10.1055/s-0039-1688474
  134. Martinez, 2018, Role of the Purkinje-Muscle Junction on the Ventricular Repolarization Heterogeneity in the Healthy and Ischemic Ovine Ventricular Myocardium, Front. Physiol., 9, 718, 10.3389/fphys.2018.00718 · doi:10.3389/fphys.2018.00718
  135. Martini, 2020, Exposure to the Natural Alkaloid Berberine Affects Cardiovascular System Morphogenesis and Functionality during Zebrafish Development, Sci. Rep., 10, 17358, 10.1038/s41598-020-73661-5 · DOI
  136. Mathiyalagan, 2019, FTO-dependent N6-Methyladenosine Regulates Cardiac Function during Remodeling and Repair, Circulation, 139, 518, 10.1161/CIRCULATIONAHA.118.033794 · DOI · Paper page
  137. Mbese, 2019, Curcumin and its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers, Molecules, 24, 4386, 10.3390/molecules24234386 · DOI · Paper page
  138. Mi, 2019, DPP-4 Inhibitors Promote Proliferation and Migration of Rat Brain Microvascular Endothelial Cells under Hypoxic/High-Glucose Conditions, Potentially through the SIRT1/HIF-1/VEGF Pathway, CNS Neurosci. Ther., 25, 323, 10.1111/cns.13042 · DOI
  139. MohanKumar, 2019, A Murine Neonatal Model of Necrotizing Enterocolitis Caused by Anemia and Red Blood Cell Transfusions, Nat. Commun., 10, 3494, 10.1038/s41467-019-11199-5 · DOI
  140. Monteiro, 2019, Endothelial Function and Dysfunction in the Cardiovascular System: The Long Non-coding Road, Cardiovasc. Res., 115, 1692, 10.1093/cvr/cvz154 · DOI
  141. Montero, 2019, The Role of Blood Volume in Cardiac Dysfunction and Reduced Exercise Tolerance in Patients with Diabetes, Lancet Diabetes Endocrinol., 7, 807, 10.1016/S2213-8587(19)30119-6 · DOI
  142. Moreno, 2018, Targeting Inflammation in Diabetic Nephropathy: A Tale of Hope, Expert Opin. Investig. Drugs, 27, 917, 10.1080/13543784.2018.1538352 · DOI · Paper page
  143. Nagel, 2006, Role of Nuclear Ca2+/Calmodulin-Stimulated Phosphodiesterase 1A in Vascular Smooth Muscle Cell Growth and Survival, Circ. Res., 98, 777, 10.1161/01.RES.0000215576.27615.fd · DOI
  144. Noh, 2017, Beta 2-Adrenergic Receptor Agonists Are Novel Regulators of Macrophage Activation in Diabetic Renal and Cardiovascular Complications, Kidney Int., 92, 101, 10.1016/j.kint.2017.02.013 · DOI · Paper page
  145. Oduro, 2020, Pharmacological Management of Vascular Endothelial Dysfunction in Diabetes: TCM and Western Medicine Compared Based on Biomarkers and Biochemical Parameters, Pharmacol. Res., 158, 104893, 10.1016/j.phrs.2020.104893 · DOI
  146. Olesen, 2021, Peripheral Artery Disease, Lower Limb Revascularization, and Amputation in Diabetes Patients with and without Coronary Artery Disease: A Cohort Study from the Western Denmark Heart Registry, BMJ Open Diabetes Res. Care, 9, e001803, 10.1136/bmjdrc-2020-001803 · DOI · Paper page
  147. Ottolini, 2020, Local Peroxynitrite Impairs Endothelial Transient Receptor Potential Vanilloid 4 Channels and Elevates Blood Pressure in Obesity, Circulation, 141, 1318, 10.1161/CIRCULATIONAHA.119.043385 · DOI
  148. Ottolini, 2019, Calcium Signals that Determine Vascular Resistance, Wiley Interdiscip. Rev. Syst. Biol. Med., 11, e1448, 10.1002/wsbm.1448 · DOI
  149. Parikh, 2020, Cardioprotective Effects of Dietary Flaxseed Post-Infarction Are Associated with Changes in MicroRNA Expression, Biomolecules, 10, 1297, 10.3390/biom10091297 · DOI
  150. Paul, 2019, Berberine Mitigates High Glucose-Potentiated Platelet Aggregation and Apoptosis by Modulating Aldose Reductase and NADPH Oxidase Activity, Free. Radic. Biol. Med., 130, 196, 10.1016/j.freeradbiomed.2018.10.453 · DOI · Paper page
  151. Pearson, 2019, Type 2 Diabetes: A Multifaceted Disease, Diabetologia, 62, 1107, 10.1007/s00125-019-4909-y · DOI · Paper page
  152. Pierelli, 2017, Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases, Oxid. Med. Cel. Longev., 2017, 7348372, 10.1155/2017/7348372 · DOI · Paper page
  153. Poh, 2021, AIM2 Inflammasome Mediates Apoptotic and Pyroptotic Death in the Cerebellum Following Chronic Hypoperfusion, Exp. Neurol., 346, 113856, 10.1016/j.expneurol.2021.113856 · DOI
  154. Pyšná, 2019, Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and Their Therapeutic Potential, Stem Cell Rev Rep, 15, 157, 10.1007/s12015-018-9863-4 · DOI
  155. Qiu, 2008, Isolation and Identification of Urinary Metabolites of Berberine in Rats and Humans, Drug Metab. Dispos., 36, 2159, 10.1124/dmd.108.021659 · DOI
  156. Qiu, 2017, Effect of Berberine on PPARα-NO Signalling Pathway in Vascular Smooth Muscle Cell Proliferation Induced by Angiotensin IV, Pharm. Biol., 55, 227, 10.1080/13880209.2016.1257642 · DOI
  157. Rajabi, 2021, Quercetin, Perillyl Alcohol, and Berberine Ameliorate Right Ventricular Disorders in Experimental Pulmonary Arterial Hypertension: Effects on miR-204, miR-27a, Fibrotic, Apoptotic, and Inflammatory Factors, J. Cardiovasc. Pharmacol., 77, 777, 10.1097/FJC.0000000000001015 · doi:10.1097/fjc.0000000000001015
  158. Raza, 2020, Sphingosine 1-Phosphate Signaling in Ischemia and Reperfusion Injury, Prostaglandins Other Lipid Mediat, 149, 106436, 10.1016/j.prostaglandins.2020.106436 · DOI
  159. Reddy, 2015, Epigenetic Mechanisms in Diabetic Complications and Metabolic Memory, Diabetologia, 58, 443, 10.1007/s00125-014-3462-y · DOI · Paper page
  160. Ren, 2019, Salvia Miltiorrhiza in Treating Cardiovascular Diseases: A Review on its Pharmacological and Clinical Applications, Front. Pharmacol., 10, 753, 10.3389/fphar.2019.00753 · DOI · Paper page
  161. Riccardi, 2021, Dietary Recommendations for Prevention of Atherosclerosis, Cardiovasc. Res. Cvab, 173, 1, 10.1093/cvr/cvab173 · DOI · Paper page
  162. Robles-Rivera, 2020, Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay its Progression: The Importance of Oxidative Stress and Inflammation, Oxid. Med. Cel. Longev., 2020, 3096470, 10.1155/2020/3096470 · DOI
  163. Russo, 2018, Properties and Functions of Adipose Tissue Macrophages in Obesity, Immunology, 155, 407, 10.1111/imm.13002 · DOI · Paper page
  164. Ryuk, 2012, Discrimination of Phellodendron Amurense and P. Chinense Based on DNA Analysis and the Simultaneous Analysis of Alkaloids, Arch. Pharm. Res., 35, 1045, 10.1007/s12272-012-0612-y · doi:10.1007/s12272-012-0612-y
  165. Safar, 2018, Arterial Stiffness as a Risk Factor for Clinical Hypertension, Nat. Rev. Cardiol., 15, 97, 10.1038/nrcardio.2017.155 · DOI · Paper page
  166. Sahibzada, 2021, Bioavailability and Hepatoprotection Enhancement of Berberine and its Nanoparticles Prepared by Liquid Antisolvent Method, Saudi J. Biol. Sci., 28, 327, 10.1016/j.sjbs.2020.10.006 · doi:10.1016/j.sjbs.2020.10.006
  167. Salvio, 2021, Hyperhomocysteinemia: Focus on Endothelial Damage as a Cause of Erectile Dysfunction, Ijms, 22, 418, 10.3390/ijms22010418 · DOI
  168. Searls, 2010, Intracellular Ca2+ Regulating Proteins in Vascular Smooth Muscle Cells Are Altered with Type 1 Diabetes Due to the Direct Effects of Hyperglycemia, Cardiovasc. Diabetol., 9, 8, 10.1186/1475-2840-9-8 · DOI
  169. Seki, 2017, Downregulation of Endothelial Transient Receptor Potential Vanilloid Type 4 Channel and Small-Conductance of Ca2+-Activated K+ Channels Underpins Impaired Endothelium-dependent Hyperpolarization in Hypertension, Hypertension, 69, 143, 10.1161/HYPERTENSIONAHA.116.07110 · DOI
  170. Shan, 2013, Berberine Analogue IMB-Y53 Improves Glucose-Lowering Efficacy by Averting Cellular Efflux Especially P-Glycoprotein Efflux, Metabolism, 62, 446, 10.1016/j.metabol.2012.09.009 · DOI
  171. Sharaky, 2020, Design, Synthesis and Biological Evaluation of a New Thieno[2,3-D]pyrimidine-Based Urea Derivative with Potential Antitumor Activity against Tamoxifen Sensitive and Resistant Breast Cancer Cell Lines, J. Enzyme Inhib. Med. Chem., 35, 1641, 10.1080/14756366.2020.1804383 · DOI
  172. Sharifi Kia, 2021, Current Understanding of the Right Ventricle Structure and Function in Pulmonary Arterial Hypertension, Front. Physiol., 12, 641310, 10.3389/fphys.2021.641310 · DOI
  173. Singh, 2021, Plant Isoquinoline Alkaloids: Advances in the Chemistry and Biology of Berberine, Eur. J. Med. Chem., 226, 11389, 10.1016/j.ejmech.2021.113839 · DOI · Paper page
  174. Sitia, 2010, From Endothelial Dysfunction to Atherosclerosis, Autoimmun. Rev., 9, 830, 10.1016/j.autrev.2010.07.016 · DOI · Paper page
  175. Sun, 2016, Loss of Renal Peritubular Capillaries in Hypertensive Patients Is Detectable by Urinary Endothelial Microparticle Levels, Hypertension, 72, 1180, 10.1161/HYPERTENSIONAHA.118.11766 · DOI
  176. Sun, 2021, Melatonin Ameliorates Hypertension in Hypertensive Pregnant Mice and Suppresses the Hypertension-Induced Decrease in Ca2+-Activated K+ Channels in Uterine Arteries, Hypertens. Res., 44, 1079, 10.1038/s41440-021-00675-5 · DOI
  177. Tan, 2021, Berberine Ameliorates Vascular Dysfunction by a Global Modulation of lncRNA and mRNA Expression Profiles in Hypertensive Mouse Aortae, PLoS One, 16, e0247621, 10.1371/journal.pone.0247621 · doi:10.1371/journal.pone.0247621
  178. Tan, 2020, Improvement of Endothelial Dysfunction of Berberine in Atherosclerotic Mice and Mechanism Exploring through TMT-Based Proteomics, Oxid. Med. Cel. Longev., 2020, 8683404, 10.1155/2020/8683404 · DOI
  179. Tang, 2016, Renoprotective Effects of Berberine and its Potential Effect on the Expression of β-arrestins and Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Streptozocin-Diabetic Nephropathy Rats, J. Diabetes, 8, 693, 10.1111/1753-0407.12349 · DOI
  180. Tang, 2021, TMSB4 Overexpression Enhances the Potency of Marrow Mesenchymal Stromal Cells for Myocardial Repair, Front. Cell Dev. Biol., 9, 670913, 10.3389/fcell.2021.670913 · doi:10.3389/fcell.2021.670913
  181. Tang, 2020, Innate Immunity in Diabetic Kidney Disease, Nat. Rev. Nephrol., 16, 206, 10.1038/s41581-019-0234-4 · DOI · Paper page
  182. Tavares, 2021, Effect of Phytosterol Capsule Supplementation Associated with the National Cholesterol Education Program Step 2 Diet on Low-Density Lipoprotein in Children and Adolescents with Dyslipidemia: A Double-Blind Crossover Trial, Nutrition, 82, 111051, 10.1016/j.nut.2020.111051 · DOI
  183. Tavernier, 2020, Apolipoprotein M: New Connections with Diet, Adipose Tissue and Metabolic Syndrome, Curr. Opin. Lipidol., 31, 8, 10.1097/MOL.0000000000000654 · DOI
  184. Toledo, 2015, Renal Resistive Index and Mortality in Chronic Kidney Disease, Hypertension, 66, 382, 10.1161/HYPERTENSIONAHA.115.05536 · DOI
  185. Tong, 2019, Antitumor Effects of Berberine on Gliomas via Inactivation of Caspase-1-Mediated IL-1β and IL-18 Release, Front. Oncol., 9, 364, 10.3389/fonc.2019.00364 · DOI
  186. Treviño-Saldaña, 2017, Regulation of Sirtuin-Mediated Protein Deacetylation by Cardioprotective Phytochemicals, Oxid. Med. Cel. Longev., 2017, 1750306, 10.1155/2017/1750306 · DOI
  187. Tsai, 2018, Surgical Adhesions in Mice Are Derived from Mesothelial Cells and Can Be Targeted by Antibodies against Mesothelial Markers, Sci. Transl. Med., 10, eaan6735, 10.1126/scitranslmed.aan6735 · DOI · Paper page
  188. Vanhoutte, 2005, Endothelium-Dependent Contractions in Hypertension, Br. J. Pharmacol., 144, 449, 10.1038/sj.bjp.0706042 · DOI · Paper page
  189. Vara, 2019, A Novel Combinatorial Technique for Simultaneous Quantification of Oxygen Radicals and Aggregation Reveals Unexpected Redox Patterns in the Activation of Platelets by Different Physiopathological Stimuli, Haematologica, 104, 1879, 10.3324/haematol.2018.208819 · DOI
  190. Verhaar, 2020, Gut Microbiota in Hypertension and Atherosclerosis: A Review, Nutrients, 12, 2982, 10.3390/nu12102982 · DOI · Paper page
  191. Waclawovsky, 2021, Individuals with Controlled Hypertension Show Endothelial Integrity Following a Bout of Moderate-Intensity Exercise: Randomized Clinical Trial, Sci. Rep., 11, 8528, 10.1038/s41598-021-87990-6 · DOI
  192. Wande, 2020, Berberine Alleviates Pulmonary Hypertension through Trx1 and β-catenin Signaling Pathways in Pulmonary Artery Smooth Muscle Cells, Exp. Cel. Res., 390, 111910, 10.1016/j.yexcr.2020.111910 · DOI
  193. Wang, 2021, FUNDC1-Dependent Mitochondria-Associated Endoplasmic Reticulum Membranes Are Involved in Angiogenesis and Neoangiogenesis, Nat. Commun., 12, 2616, 10.1038/s41467-021-22771-3 · DOI
  194. Wang, 2015, Berberine via Suppression of Transient Receptor Potential Vanilloid 4 Channel Improves Vascular Stiffness in Mice, J. Cel. Mol. Med., 19, 2607, 10.1111/jcmm.12645 · DOI · Paper page
  195. Wang, 2019, Coptidis Rhizoma: A Comprehensive Review of its Traditional Uses, Botany, Phytochemistry, Pharmacology and Toxicology, Pharm. Biol., 57, 193, 10.1080/13880209.2019.1577466 · DOI · Paper page
  196. Wang, 2020, Berberine Inhibits Proliferation and Apoptosis of Vascular Smooth Muscle Cells Induced by Mechanical Stretch via the PDI/ERS and MAPK Pathways, Life Sci., 259, 118253, 10.1016/j.lfs.2020.118253 · DOI
  197. Wang, 2011, Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2, PLoS One, 6, e25436, 10.1371/journal.pone.0025436 · DOI · Paper page
  198. Wang, 2018, Endoplasmic Reticulum Stress in the Heart: Insights into Mechanisms and Drug Targets, Br. J. Pharmacol., 175, 1293, 10.1111/bph.13888 · DOI · Paper page
  199. Wang, 2015, Berberine Protects Vascular Endothelial Cells in Hypertensive Rats, Int. J. Clin. Exp. Med., 8, 14896
  200. Wang, 2009, Berberine Prevents Hyperglycemia-Induced Endothelial Injury and Enhances Vasodilatation via Adenosine Monophosphate-Activated Protein Kinase and Endothelial Nitric Oxide Synthase, Cardiovasc. Res., 82, 484, 10.1093/cvr/cvp078 · DOI · Paper page

200 of 239 shown

Cited by

See all 218

Metadata

Authors
Ai, X., Yu, P., Peng, L., Luo, L., Liu, J., Li, S., Lai, X., Luan, F., & Meng, X.
Venue
Frontiers in Pharmacology
Published
2021-11-03
Volume
12
Pages
762654-762654
ISSN
1663-9812 (ISSN-L)
OpenAlex
W3211775389
Cited by
218
References
32
FWCI
9.47
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.